The extended renin-angiotensin system: a promising target for traumatic brain injury therapeutics

查看全文 作　　者：Zachary [1]C.Janatpour;Aviva [1]J.Symes

机构地区：[1]Department of Pharmacology, Uniformed Services University

出　　处：《Neural Regeneration Research》索引2020年第15卷第6期,共2页

摘　　要：Traumatic brain injury(TBI)is a leading cause of death and disability worldwide.Global assessments estimate that over 27 million cases of TBI occur annually,resulting in over 8 million years lived with disability(GBD 2016 Dementia Collaborators,2019).Over 30 clinical trials have failed to show efficacy in TBI,and patients are currently left without any promising therapeutic options(Villapol et al.,2015).The pathophysiology of TBI is commonly divided into primary and secondary injuries.Primary injury refers to the parenchymal damage that occurs as an immediate consequence of acute kinetic energy transfer to the brain(i.e.,membrane rupture,hemorrhage,axotomy,etc.).Secondary injury encompasses the deleterious molecular and cellular responses that occur in response to the primary injury in the minutes,hours or days following.The search for therapeutics that mitigate the effects of the secondary injury and/or assist endogenous repair processes remains a large focus of TBI research(Umschweif et al.,2014;Villapol et al.,2015;Janatpour et al.,2019). 关键词：INJURIES ENDOGENOUS INJURY

相关文献

参考文献（12）
引证文献（3）
耦合文献（0）

参考文献(12)

引证文献(3)

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

The extended renin-angiotensin system: a promising target for traumatic brain injury therapeutics

参考文献(12)

引证文献(3)

用户提示